Meta shows off prototype augmented-reality glasses at Connect event
By Katie Paul MENLO PARK, California (Reuters) -Facebook owner Meta Platforms showed off its first working prototype of augmented-reality glasses, called Orion, during its annual
Trump says he will put 100% tariffs on every car coming across Mexico border
(Reuters) – Republican presidential candidate Donald Trump said on Tuesday that he will put a 100% tariff on every car coming into the United States
US State Dept OKs potential sale of Stinger missiles to Egypt for $740 million
WASHINGTON (Reuters) – The U.S. Department of State has approved the potential sale of 720 Stinger missiles to Egypt for $740 million, the Pentagon said
Microsoft to spend $1.3 billion in Mexico on cloud, AI tech
MEXICO CITY (Reuters) -Tech giant Microsoft will invest $1.3 billion over the next three years to build up its infrastructure in Mexico for cloud computing
Boeing offers additional time to striking union workers to vote on new offer
(Reuters) – Boeing said on Tuesday it has offered additional time and support to the union representing thousands of its striking workers in the U.S.
Hedge funds snap up US tech stocks amid falling rates, says Goldman Sachs
By Nell Mackenzie LONDON (Reuters) – Hedge funds bought U.S. tech and media stocks at the fastest pace in four months last week, said a
Qualcomm’s potential Intel buyout could raise antitrust, foundry concerns
By Aditya Soni and Yuvraj Malik (Reuters) – A potential deal to buy Intel could accelerate Qualcomm’s diversification but will burden the smartphone chipmaker with
White House touts $1 billion fund to help auto suppliers retool for EVs
By David Shepardson WASHINGTON (Reuters) – Investment firm Monroe Capital LLC said on Monday it plans to launch a fresh fund of up to $1
Trump Media shares tumble to new lows after insider selling curbs expire
Shares of former U.S. President Donald Trump’s media company tumbled over 5% to a new low on Monday, extending recent losses after restrictions on insider
Novo Nordisk shares drop nearly 5% on disappointing obesity pill data
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -Novo Nordisk’s shares fell nearly 5% on Friday after results from a Phase 2a trial of the